Weed (BUDZ) Capital Expenditures (2010 - 2023)

Weed's (BUDZ) quarterly Capital Expenditures came in at $10000.0 in Q1 2023, down 96.26% quarter-over-quarter from $267499.0 in Q4 2021.

Weed (BUDZ) Capital Expenditures (2010 - 2023) Analysis & Trends

Weed's Capital Expenditures history runs 8 years deep, the most recent figure standing at $10000.0 for Q1 2023.

  • On a quarterly basis, Capital Expenditures changed N/A year-over-year to $10000.0 in Q1 2023; TTM through Dec 2023 was $10000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $10000.0, changed N/A from the prior year.
  • Capital Expenditures eased to $10000.0 in Q1 2023 per BUDZ's latest filing, from $267499.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $267499.0 in Q4 2021 and bottomed at -$163590.0 in Q3 2020.
  • The 4-year median for Capital Expenditures is $6867.0 (2021), against an average of $47368.7.
  • Across the five-year window, Capital Expenditures slumped 99.13% in 2019 and surged 63.52% in 2021, its largest moves.
  • Year by year, Capital Expenditures stood at $2979.0 in 2019, then jumped by 5391.44% to $163590.0 in 2020, then jumped by 63.52% to $267499.0 in 2021, then slumped by 96.26% to $10000.0 in 2023.
  • Per Business Quant, the three latest BUDZ Capital Expenditures figures stand at $10000.0 (Q1 2023), $267499.0 (Q4 2021), and $3734.0 (Q1 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Weed 3.72 Mn 3.72 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 10,000.00
Mar 31, 2023 10,000.00
Dec 31, 2021 267,499.00
Dec 31, 2021 267,499.00
Mar 31, 2021 3,734.00
Mar 31, 2021 3,734.00
Dec 31, 2020 163,590.00
Dec 31, 2020 163,590.00
Sep 30, 2020 -163,590.00
Sep 30, 2020 -163,590.00
Mar 31, 2019 2,979.00
Mar 31, 2019 2,979.00
Sep 30, 2018 475,761.00
Sep 30, 2018 475,761.00
Jun 30, 2018 10,067.00
Jun 30, 2018 10,067.00
Mar 31, 2018 340,653.00
Mar 31, 2018 340,653.00
Dec 31, 2017 24,755.00
Dec 31, 2017 24,755.00